Background and Aim: Sepsis is characterized by loss of control of the inflammatory response, which can be triggered by various microorganisms and toxic secretions. The mortality rate increases due to impaired endothelial function caused dysfunctional organ systems. Diabetes is closely related to sepsis. The study aimed to determine the method of using animal models of sepsis diabetes through a combination of streptozotocin (STZ) and Staphylococcus aureus infection based on biological marker parameters.

Materials and Methods: A total of 30 male Wistar rats of 2.5-3 months old weighing approximately 150-250 g body weight (BW) divided into six treatment groups with five replications per group were used in the study. Treatment A was negative control (healthy rats) and Treatment B was the positive control (with diabetes) where rats were given STZ dose at 45 mg/kg BW on day 8 intraperitoneally (IP). The blood glucose was measured on day 10, Treatment C was a positive control (bacteria), rats inoculated with S. aureus with a concentration of 10⁸ CFU/mL on day 8 given IP and observed sepsis conditions on day 10th. Treatment group (D, E, and F): Rats given STZ dose at 45 mg/kg BW on day 8th by IP and measured blood glucose on day 10th, then inoculated with S. aureus with different concentrations of 10⁵ CFU/mL, 10⁶ CFU/mL, and 10⁷ CFU/mL on the 10th day, respectively, and were later observed the condition of sepsis on day 12th. Data on diabetes bacteremia were quantitative used blood glucose levels, the bacterial count, and C-reactive protein (CRP) and were analyzed using the one-way analysis of variance test with a confidence level of 95%. Physical examination (temperature and respiration) is qualitative.

Results: Physical examination showed that all treatments had a normal temperature, an increased pulse in Groups D, E, and F and a decrease in respiratory rate in the treatment of E and F, the bacteria found in the vital organs in all groups, and CRP levels were not significantly different at all.

Conclusion: Animal model of diabetes sepsis can be observed through a combination of pancreas damage, and respiration, the bacteria in the vital organs.

Keywords: animal model, diabetes, inflammation, sepsis.

1. Fox-Robichaud, A., Mai, S., Khan, M. and Patricia, L. (2012) Experimental Sepsis Model. Available from: http://www.intechopen.com/books/sepsis-an-ongoing-andsignificant- Challenge. Last accessed on 09-12-2018.

2. Osuchowski, M.F, Florin, L.C., Elizabeth, S., Corneliu, S., Robert, S. and Daniel, G.R. (2010) Untreated Type 1 diabetes increases sepsis-induced mortality without inducing a pre-lethal cytokine response. Shock, 34(4): 369-376. [Crossref] [PubMed] [PMC]

3. Kenney, E.M. (2010) Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J. Am. Vet. Med. Assoc., 236(1): 83-87. [Crossref] [PubMed]

4. Schuetz, P., Pedro, C.A. and Athan, I.S.H. (2011a) Diabetes and sepsis: Preclinical findings and clinical relevance. Diabetes Care, 34(3): 771-778. [Crossref] [PubMed] [PMC]

5. Rastogi, A. and Anil, B. (2016) Diabetes foot infection: An Indian scenario. J. Foot Ankle Surg. (Asia-Pacific), 3(2): 71-79.

6. Dask, A.K., Mishra, J. and Dask, D.K. (2014) Antidiabetes activity and modulation of antioxidant status by Ocimum americanum in streptozotocin-induced diabetes rats. Eur. Sci. J., 10(6): 168-177.

7. Singh, M.P. and Pathak, K. (2015) Animal models for biological screening of anti-diabetic drugs: An overview. Eur. J. Exp. Biol., 5(5): 37-48.

8. Wu, D., Shusheng, Z., Shijing, H. and Bao, L. (2017) Inflammatory responses and histopathological changes in a mouse model of S. aureus induced bloodstream infections. J. Infect. Dev. Ctries., 11(4): 294-305. [Crossref] [PubMed]

9. Reis, C.P., Figueiredo, I.V., Rui, A.C, Jone, J., Nunes, P., Soares, A.F., Silva, C.F., Ribeiro, A.J., Veiga, F.J., Damge, C., Cabrita, A.N.M. and Neufeld, R.J. (2008) Toxicological assessment of orally delivered nanoparticulate insulin. Nanotoxicology, 2(4): 205-217. [Crossref]

10. Damasceno, D.C., Netto, A.O., Iessi, I.L., Gallego, F.Q., Corvino, S.B., Dallaqua, B., Sinzato, Y.K., Bueno, A., Calderon, I.M.P. and Rudge, M.V.C. (2014) Review article streptozotocin-induced diabetes models: Pathophysiological mechanisms and fetal outcomes. BioMed Res. Int., 2014: 1-11. [Crossref] [PubMed] [PMC]

11. Hasibuan, M.S., Yasni, S., Bintang, M. and Ranti, A.S. (2016) Antihyperglycemic activity of Piper crocatum leaves and Cinnamomum burmanii bark mixture extract in streptozotocin-induced diabetes rats. J. Math. Fund. Sci., 48(2): 178-191. [Crossref]

12. Aslam, F., Iqbal, S., Nasir, M., Anjum, A.A., Swan, P. and Sweazea, K (2017) Evaluation of white sesame seed oil on glucose control and biomarkers of hepatic, cardiac, and renal functions in male Sprague-Dawley rats with chemically induced diabetes. J. Med. Food, 20(5): 448-457. [Crossref] [PubMed] [PMC]

13. Popov, D. and Paplov, G. (2007) Sepsis models in experimental animals. Trakia J. Sci., 11(1): 13-23.

14. Santana, S., Lenzi-Almeida, K.C., Fernandes-Santos, C., Paes-De-Almeida, E. and Aguiar-Alves, F. (2016) Rat infection by methicillin-resistant S. aureus from different colonization sites in humans resulting in diffusion to multiple organs. J. Clin. Exp. Pathol., 6(2016): 283. [Crossref]

15. Hanses, F., Roux, C., Dunman, P.M., Salzberger, B. and Lee, J.C. (2014) S. aureus gene expression in a rat model of infective endocarditis. Genome Med., 6(10): 93. [Crossref] [PubMed] [PMC]

16. Mai, S., Khan, M., Liaw, P. and Fox-Robichaud, A. (2007) Experimental Sepsis Model. An Ongoing and Significant Challenge. Available from: http://www.intechopen.com/books/sepsis-an-ongoing-andsignificant-challenge. Last accessed on 10-12-2018.

17. Li-Tzu, Y., Yi-Ping, C., Shyi-Jou, C., Chin-Chen, C. and Huey-Kang, S. (2014) Diabetes animal models with infectious diseases: Focus on the dysfunction of the immune system. J. Diabetes Metab., 5(8): 417.

18. Padilla, N.B., Bleeker, W.K., Lubbers, Y., Rigters, G.M.M., Mierlo, G.J.V., Daha, M.R. and Hack, C.E. (2007) Rat C-reactive protein activates the autologous complement system. Immunology, 109(4): 564-571. [Crossref] [PubMed] [PMC]

19. Lelubre, C., Anselin, S., Boudjeltia, K.Z., Biston, P and Piagnerelli, M. (2013) Interpretation of C-reactive protein concentrations in critically ill patients. BioMed Res. Int., 2013: Article ID 124021. [Crossref] [PubMed] [PMC]

20. Dimitrov, I., Kamenov, V., Angelova, P. and Petrov, M. (2014) Concentration of C-reactive protein in white adipose tissue, liver and blood serum of male Wistar rats. Trakia J. Sci., 12(1): 29-33.

21. Rittirsch, D., Marco, H. and Peter, A.W. (2007) The disconnect between animal models of sepsis and human sepsis. J. Leukoc. Biol., 81(1): 137-143. [Crossref] [PubMed]

22. Menon, M.S., Marwah, S., Mehta, M. and Dipak, A.D. (2014) Diagnostic accuracy of CRP in immunocompromised patients with sepsis in intensive care units. Natl. J. Physiol. Pharm. Pharmacol., 5(3): 166-169. [Crossref]

23. Schnoor, M., Alcaide, P., Mathieu-Benoit V. and Buul, J.D.V. (2016) Recruitment of immune cells into inflamed tissues: Consequences for endothelial barrier integrity and tissue functionality. Mediat. Inflamm., 2016 : 1-24. [Crossref] [PubMed] [PMC]